Tag: Aquavit Pharmaceuticals

All

Aquavit Files Investigation of New Drug for New Botulinum Toxin

Aquavit Pharmaceuticals, Inc. has submitted to the U.S. FDA an Investigation of New Drug package for a new botulinum toxin, DTX-021.

All

Sorry, No Posts Found

All

Patient Perspective as Clinical Data: Dr Steven Dayan on PROs and Aesthetic Outcomes

Dr Steven Dayan discusses how patient-reported outcomes (PROs) are shaping clinical research, regulatory standards, and patient care in aesthetic medicine.

Cold Ablative Fiber Laser Gains Regulatory Approval in Canada
AAD Issues Strong Recommendations for Four Therapies in Updated Atopic Dermatitis Guidelines
The Aesthetic Society Updates Its Educational Platform with Netflix-Style Interface

Tag: Aquavit Pharmaceuticals

All

Aquavit Files Investigation of New Drug for New Botulinum Toxin

All

Sorry, No Posts Found

All

Patient Perspective as Clinical Data: Dr Steven Dayan on PROs and Aesthetic Outcomes

Cold Ablative Fiber Laser Gains Regulatory Approval in Canada

AAD Issues Strong Recommendations for Four Therapies in Updated Atopic Dermatitis Guidelines

The Aesthetic Society Updates Its Educational Platform with Netflix-Style Interface

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links